A detailed history of Summit Tx Capital, L.P. transactions in Grifols Sa stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 80,514 shares of GRFS stock, worth $632,034. This represents 0.02% of its overall portfolio holdings.

Number of Shares
80,514
Holding current value
$632,034
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$6.62 - $8.71 $533,002 - $701,276
80,514 New
80,514 $572 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Summit Tx Capital, L.P. Portfolio

Follow Summit Tx Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Tx Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Summit Tx Capital, L.P. with notifications on news.